KD
Ke Ding
Shanghai Institute of Organic Chemistry, Jinan University, Fudan University, China Pharmaceutical University, Guangzhou Institutes of Biomedicine and Health
0000-0001-9016-812X
Employment
-
Shanghai Institute of Organic Chemistry Prof.2023 - Present
-
Jinan University professor2016 - Present
-
Guangzhou Institutes of Biomedicine and Health Professor2006 - 2016
-
University of Michigan postdoctor/research Investigator2001 - 2006
Education
-
Fudan University1998 - 2001
-
China Pharmaceutical University Master1995 - 1998
-
China Pharmaceutical University Bachelar1991 - 1995
Projects & Funding
Projects & funding information is unavailable.
Publications (163)
- Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor Save
- Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors Save
- Chemical Adaptation in Drug Discovery: The Medicinal Chemistry Journey of Olverembatinib and Limertinib in Overcoming Kinase Drug Resistance Save
- Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitor Save
- Discovery of CZY43 as a new small-molecule degrader of pseudokinase HER3 Save
- Proteome-wide Ligand and Target Discovery by Using Strain-Enabled Cyclopropane Electrophiles Save
- Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor Save
- Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors Save
- Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors Save
- Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibitors Save